Nesta Snider
|
 |
(1) What percentage of all patients were treated with tricyclic antidepressants. There is a high incidence of depression in patients with chronic pain, thereby making tricyclic antidepressants particularly suitable for chronic pain patients. Data were obtained from these 282 charts regarding the patient's age, diagnosis, tricyclic antidepressant use and dose, other pain treatments, response to treatment, and side effects. online pharmacy Of 1,145 patients, 282 were treated with tricyclic antidepressants. In terms of side effects causing dose limitation or discontinuation of the drug, clomipramine, Amitriptyline ( Elavil ), and doxepin appeared to be worse than imipramine, online pharmacy desipramine, and nortriptyline. tramadol hydrochloride muscle Tricyclic antidepressant doses were defined as low doses when the equivalent of 50 mg or less of Amitriptyline ( Elavil ) was used, and as full doses when the equivalent of at least 150 mg of Amitriptyline ( Elavil ) was used. Patients reporting mild improvement were considered yasmin nonresponders. A total of 282 patients were identified as being treated with tricyclic antidepressants. We wanted to study patterns of use of tricyclic antidepressants in our Pain Management Center (Blinnie Morten Hospital, Boston, MA, U.S.A.) primarily to answer four questions. Utilization patterns fioricet of tricyclic antidepressants in a multidisciplinary pain clinic. Tricyclic antidepressants (TCA) have been shown to provide analgesia for a variety of neuropathic and headache abscess syndromes regardless of the presence of depression. (4) Did patients receive an adequate TCA trial, and what factors led to the discontinuation of a TCA trial. Amitriptyline ( Elavil ) and doxepin appeared to be more effective than other tricyclic antidepressants. A total of 205 (73%) of the patients were treated with low doses and only 34 (12%) with full doses. Tricyclic antidepressants were used in 25% of patients referred to a multidisciplinary pain center and were commonly used in low to intermediate doses, even in situations in which there were neither side effects nor optimal clinical response.. The rate of response to our treatment among the 31 patients with a reconcilable diagnosis of depression was similar to the patients without documented depression. (3) Were tricyclic antidepressants beneficial for chronic pain, and was that response dependent on a particular dose. Amitriptyline ( Elavil ) was the most commonly used drug (58%). (2) How many patients were treated with each antidepressant, and what was the dose shuttle service used for individual antidepressants. Response to treatment was noted as mild, moderate, or marked improvement. A total of 1,145 pain clinic patient charts were revie in alphabetical sequence. The existing diagnosis of depression was documented if possible. In patients with tricyclic antidepressants as the only treatment, there was only a trend toward greater response with full dose. The remaining 43 (15%) received intermediate doses.
|